Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: Results of the Paediatric Onset Study (ONSET) after 12 months of treatment

Diabetologia

Volumn 53, Issue 12, 2010, Pages 2487-2495

  Kordonouri, O ^a   Pankowska, E ^b   Rami, B ^c   Kapellen, T ^d   Coutant, R ^e   Hartmann, R ^a   Lange, K ^f   Knip, M ^g,h   Danne, T ^a  

^a Bult Diabetes Centre for Children and Adolescents   (Germany)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g UNIVERSITY OF HELSINKI   (Finland)

^h TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

C peptide; Continuous glucose monitoring; Glycaemic variability; HbA 1c; Quality of life; Sensor augmented pump therapy; Severe hypoglycaemia

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ARTICLE; BIOSENSOR; BLOOD GLUCOSE MONITORING; CELL FUNCTION; CHILD; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANCREAS ISLET BETA CELL; PARENTAL BEHAVIOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SELF MONITORING; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; AGE OF ONSET; BIOSENSING TECHNIQUES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; INSULIN INFUSION SYSTEMS; MALE; QUALITY OF LIFE; TIME FACTORS;

EID: 78649335825     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1878-6     Document Type: Article

References (26)

1. CT Prince DJ Becker T Costacou RG Miller TJ Orchard 2007 Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC) Diabetologia 50 2280 2288 1:STN:280:DC%2BD2srosFagsA%3D%3D 10.1007/s00125-007-0797-7 17768606 (Pubitemid 47512402)
2. DCCT Group 1998 Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial Ann Intern Med 128 517 523
3. J Ludvigsson 2009 C-peptide an adequate endpoint in type 1 diabetes Diabetes Metab Res Rev 25 691 693 1:CAS:528:DC%2BD1MXhsFClur7M 10.1002/dmrr.1035 19877135
4. BS Levin BJ Anderson DA Butler JE Antisdel J Brackett LMB Laffel 2001 Predictors of glycaemic control and short-term adverse outcomes in youth and with type 1 diabetes J Pediatr 139 197 203 10.1067/mpd.2001.116283 (Pubitemid 32721704)
5. D Deiss J Bolinder J-P Riveline, et al. 2006 Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring Diab Care 29 2730 2732 10.2337/dc06-1134 (Pubitemid 44912209)
6. T Danne HW de Valk T Kracht, et al. 2009 Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology Diabetologia 52 1496 1503 1:STN:280: DC%2BD1MvotVyrtQ%3D%3D 10.1007/s00125-009-1408-6 19526212
7. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group 2008 Continuous glucose monitoring and intensive treatment of type 1 diabetes N Engl J Med 359 1464 1476 10.1056/NEJMoa0805017
8. FJ Service GD Molnar Rosevear E Ackermann LC Gatweood WF Taylor 1970 Mean amplitude of glycemic excursions, a measure of diabetic instability Diabetes 19 644 655 1:CAS:528:DyaE3MXktVWiur8%3D 5469118
9. M Rewers C Pihoker K Donaghue R Hanas P Swift GJ Klingensmith 2009 ISPAD Clinical Practice Consensus Guidelines 2009. Assessment and monitoring of glycemic control in children and adolescents with diabetes Pediatr Diab 10 Suppl. 12 71 81 10.1111/j.1399-5448.2009.00582.x
10. The Disabkids Group Europe: The Disabkids questionnaires. Quality of life questionnaires for children with chronic conditions. Lengerich: Pabst Science Publishers
11. The KIDSCREEN Group Europe. The KIDSCREEN Questionnaires. Quality of life questionnaires for children and adolescents. Lengerich: Pabst Science Publishers
12. L Rajmil J Alonso S Berra KIDSCREEN Group, et al. 2006 Use of a children questionnaire of health-related quality of life (KIDSCREEN) as a measure of needs for health care services J Adolesc Health 38 511 518 10.1016/j.jadohealth. 2005.05.022 16635761
13. World Health Organization, Regional Office for Europe (2008) Wellbeing measures in primary health care/the DEPCARE project: report on a WHO meeting, Stockholm, Sweden, 12-13 February 1998. WHO Regional Office for Europe, Copenhagen
14. P Pozzilli A Crino R Schiaffini IMDIAB Group, et al. 2003 A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8) Diab Techn Therap 5 965 974 1:CAS:528:DC%2BD3sXpvVKks7g%3D 10.1089/152091503322641006 (Pubitemid 38009934)
15. HB Mortensen PG Swift RW Holl and Hvidoere Study Group on Childhood Diabetes, et al. 2009 Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis Pediatr Diabetes 11 218 226 10.1111/j.1399-5448.2009.00566.x
16. T Wysocki R Iannoti J Weissberg-Benchell Family Management of Childhood Diabetes Steering Committee, et al. 2008 Diabetes problem solving by youths with type 1 diabetes and their caregivers: measurement, validation, and longitudinal associations with glycemic control J Pediatr Psychol 33 875 884 10.1093/jpepsy/jsn024 18346973
17. G Insabella M Grey G Knafl W Tamborlane 2007 The transition to young adulthood in youth with type 1 diabetes on intensive treatment Pediatr Diabetes 8 228 234 10.1111/j.1399-5448.2007.00266.x 17659065 (Pubitemid 47103763)
18. B Keymeulen E Vandemeulebroucke AG Ziegler, et al. 2005 Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes N Engl J Med 352 2598 2608 1:CAS:528:DC%2BD2MXls1Wqu7k%3D 10.1056/NEJMoa043980 15972866 (Pubitemid 41007846)
19. J Ludvigsson M Faresjö M Hjorth, et al. 2008 GAD treatment and insulin secretion in recent-onset type 1 diabetes N Engl J Med 359 1909 1920 1:CAS:528:DC%2BD1cXhtlaitbbF 10.1056/NEJMoa0804328 18843118
20. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group 2009 Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes Diab Care 32 1947 1953 10.2337/dc09-0889
21. J Hermanides JH DeVries 2010 Sense and nonsense in sensors Diabetologia 53 593 596 1:STN:280:DC%2BC3c7nvVelsQ%3D%3D 10.1007/s00125-009-1649-4 20225392
22. M Bullinger S Schmidt C Petersen 2002 Assessing quality of life of children with chronic health conditions and disabilities: a European approach Int J Rehabil Res 25 197 206 10.1097/00004356-200209000-00005 12352173
23. RM Bergenstal WV Tamborlane A Ahmann, et al. 2010 Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes N Engl J Med 363 311 320 1:CAS:528:DC%2BC3cXptFajtLw%3D 10.1056/NEJMoa1002853 20587585
24. CC Patterson GG Dahlquist E Gyürüs A Green G Soltész EURODIAB Study Group 2009 Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study Lancet 373 2027 2033 10.1016/S0140-6736(09)60568- 7 19481249
25. T Danne HB Mortensen P Hougaard Hvidøre Study Group on Childhood Diabetes, et al. 2001 Persistent differences among centres over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group Diab Care 24 1342 1347 1:CAS:528:DC%2BD3MXmtlGitrk%3D 10.2337/diacare.24.8.1342
26. NH White W Sun PA Cleary, et al. 2008 Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial Arch Ophthalmol 126 1707 1715 10.1001/archopht.126.12.1707 19064853